Big pharma and the business of HIV/AIDS - The Independent
HIV antiretroviral sales across the seven major markets of the US, Japan, France, Germany, Spain, Italy and the UK totalled $11.8bn (£7.6bn) last year, according to figures from the research firm Datamonitor.
